Copperwynd Financial, LLC Moderna, Inc. Transaction History

Copperwynd Financial, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 21, 2022	SELL	$126.46 - $235.05 $3 Million - $5.57 Million	-23,713 Closed	0 $0
Q4 2021 Feb 04, 2022	BUY	$225.82 - $368.51 $1.62 Million - $2.64 Million	7,158 Added 43.24%	23,713 $6.02 Million
Q3 2021 Nov 03, 2021	SELL	$221.9 - $484.47 $2.53 Million - $5.53 Million	-11,416 Reduced 40.81%	16,555 $6.37 Million
Q2 2021 Aug 12, 2021	BUY	$129.91 - $234.98 $3.63 Million - $6.57 Million	27,971 New	27,971 $6.57 Million

1,039

245M

12.1M

9.36M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $46.3B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Copperwynd Financial, LLC, based on Form 13F filings with the SEC.

Stay updated on Copperwynd Financial, LLC with notifications on news.